Drug Manufacturers Stock News
Categories
- All
- Editor's Picks
- Stock Market News
- Q&A with Gurus
- Gurus' Stock Picks
- Insider Transaction
- Earning Reports
- CEO Shareholder Letters
- Press Release
- Earnings Call Transcripts
- Instant Alerts
- Podcast
Industries
- Aerospace & Defense
- Agriculture
- Asset Management
- Banks
- Beverages - Alcoholic
- Beverages - Non-Alcoholic
- Biotechnology
- Building Materials
- Business Services
- Capital Markets
- Chemicals
- Conglomerates
- Construction
- Consumer Packaged Goods
- Credit Services
- Diversified Financial Services
- Drug Manufacturers
- Education
- Farm & Heavy Construction Machinery
- Forest Products
- Furnishings, Fixtures & Appliances
- Hardware
- Healthcare Plans
- Healthcare Providers & Services
- Homebuilding & Construction
- Industrial Distribution
- Industrial Products
- Insurance
- Interactive Media
- Manufacturing - Apparel & Accessories
- Media - Diversified
- Medical Devices & Instruments
- Medical Diagnostics & Research
- Medical Distribution
- Metals & Mining
- Oil & Gas
- Other Energy Sources
- Packaging & Containers
- Personal Services
- Real Estate
- REITs
- Restaurants
- Retail - Cyclical
- Retail - Defensive
- Semiconductors
- Software
- Steel
- Telecommunication Services
- Tobacco Products
- Transportation
- Travel & Leisure
- Utilities - Independent Power Producers
- Utilities - Regulated
- Vehicles & Parts
- Waste Management
Drug Manufacturers
Laurus Labs Ltd (BOM:540222) Q1 2025 Earnings Call Transcript Highlights: Resilient Margins Amid Flattish Revenue Growth
Despite subdued EBITDA margins and flattish revenue growth, Laurus Labs Ltd (BOM:540222) maintains strong gross margins and significant investments in future growth. Jul 27, 2024
Drug Manufacturers
Glenmark Life Sciences Ltd (BOM:543322) Q1 2025 Earnings Call Transcript Highlights: Strong Revenue Growth Amid Margin Pressures
Glenmark Life Sciences Ltd (BOM:543322) reports a 9.7% increase in revenue and a 14.1% rise in EBITDA for Q1 FY25, despite facing margin challenges and regulatory issues. Jul 27, 2024
Drug Manufacturers
Roche Holding AG (RHHBF) Q2 2024 Earnings Call Transcript Highlights: Strong Growth in Core Business Amid COVID-19 Sales Decline
Roche Holding AG (RHHBF) reports robust performance in core operations, despite challenges from COVID-19 sales decrease and loss of exclusivity impacts. Jul 26, 2024